The MedLife Center for Maternal-Fetal Medicine and Assisted Human Reproduction (MFM) registered last year a number of 340 patients that were treated with in vitro fertilization and ICSI (intracytoplasmic sperm injection, zygotic intrafallopian transfer) procedures, 30% more than the previous year, when 264 patients have used the center services. Thus, in 2013, the highest success rate was recorded in patients aged between 31 and 35 years, with most addressability registered.
IVF/ICSI 2013 Procedures
| Age group | Patients No | Carriages No. | Missed | Percentage obtained | Percentage in evolution |
| <30 | 48 | 27 | 1 | 56% | 54% |
| 31 - 35 | 141 | 76 | 8 | 54% | 48% |
| 36 – 37 | 74 | 34 | 5 | 46% | 39% |
| 38 – 40 | 50 | 15 | 4 | 30% | 22% |
| >40 | 27 | 3 | 1 | 11% | 7% |
| Total | 340 | 155 | 19 | 46% | 40% |
The MedLife Center for Maternal-Fetal Medicine and Assisted Human Reproduction, led by Dragos Albu, MD (Consultant in obstetrics and gynaecology, Assistant Professor, PhD in medicine), has emerged as a consequence of modern obstetrics and gynaecology development, encompassing a multidisciplinary physicians, academics and medicine doctors team, which aim to ensure medical care excellence services in three main directions: maternal-fetal medicine, assisted human reproduction, medical genetics.